Coherus Oncology, Inc. (CHRS) ownership: Top institutional holder: BlackRock Fund Advisors ($43.91M). Insider activity: Net Seller (0 buys, 20 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock Fund Advisors | 1559843.00 | $43.91M | 2016-12-31 |
| BlackRock, Inc. | 10365074.00 | $17.52M | 2026-03-31 |
| VANGUARD GROUP INC | 10028893.00 | $14.24M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5452762.00 | $9.22M | 2026-03-31 |
| Point72 Asset Management, L.P. | 5283292.00 | $7.29M | 2024-12-31 |
| SAMSARA BIOCAPITAL, LLC | 3428571.00 | $5.79M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3121578.00 | $5.28M | 2026-03-31 |
| Kohlberg Kravis Roberts & Co. L.P. | 3036076.00 | $5.07M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 |
Back to CHRS overview · CHRS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.